Table S1, Table S2, Table S3 from Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors

Autor: Anastasios Stathis, Cristiana Sessa, Tatiana Terrot, Mariarosa Pascale, Laura Moser, Sheila Gaggetta, Simone Brandt, Eleftherios Pierre Samartzis, Milo Frattini, Monia Guidi, Federica Martorana, Sofia Genta, Ilaria Colombo
Rok vydání: 2023
DOI: 10.1158/1078-0432.22480734
Popis: Table S1. All TEAEs at least possibly related to one or more of the study drugs by dose level. Table S2. Statistical summary of the PF-05212384 PK parameters obtained by NCA using the available rich sampling data of cycle 1 after drug administration at day 1. Table S3. Statistical summary of the PF-05212384 PK parameters obtained by NCA using rich sampling data collected until day 4 after drug administration at day 1 cycle 1 and 2.
Databáze: OpenAIRE